YOUNG HIGH RISK PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDING BCL‐2/MYC DOUBLE HIT LYMPHOMAS BENEFIT FROM DOSE‐DENSE IMMUNOCHEMOTHERAPY WITH EARLY CNS PROPHYLAXIS

  • S. Leppä (Lecturer)
  • J. Jørgensen (Other)
  • A. Tierens (Other)
  • L. Meriranta , (Other)
  • I. Østlie (Other)
  • Peter de Nully Brown (Other)
  • Unn-Merete Fagerli (Other)
  • Larsen, T. S. (Other)
  • S. Mannisto (Other)
  • Lars Munksgaard (Other)
  • M Maisenhölder (Other)
  • K Vasala (Other)
  • P Meyer (Other)
  • Mats Jerkeman (Other)
  • Magnus Bjorkholm (Other)
  • Oystein Fluge (Other)
  • Sirkku Jyrkkio (Other)
  • Elisabeth Methner Ralfkiær (Other)
  • S. Spetalen (Other)
  • Marja-Liisa Karjalainen-Lindsberg (Other)
  • H. Holte (Other)

Activity: Talks and presentationsConference presentations

Period18. Jun 2019
Event title15th International Conference on Malignant Lymphoma
Event typeConference
LocationLugano, SwitzerlandShow on map